HROW Q4 2019 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$13M+10.7% YoY

Gross Profit

$9M71.7% margin

Operating Income

$926,0007.3% margin

Net Income

$3M21.1% margin

EPS (Diluted)

$0.29

QoQ Revenue Growth

-1.2%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$683,000

Stock-Based Comp.

$465,000

Balance Sheet

Total Assets

$59M

Total Liabilities

$32M

Stockholders' Equity

$28M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$11M	+10.7%
Gross Profit	$9M	$7M	+24.1%
Operating Income	$926,000	-$2M	+142.8%
Net Income	$3M	$18M	-85.3%

Revenue Segments

License Revenues

$7,000100%